{"id":"W4401182078","doi":"10.1007/s40801-024-00428-z","title":"Comparison of Real-World On-Label Treatment Persistence in Patients with Psoriatic Arthritis Receiving Guselkumab Versus Subcutaneous Tumor Necrosis Factor Inhibitors","year":2024,"lang":"en","type":"article","venue":"Drugs - Real World Outcomes","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Saskatchewan","funders":"Janssen Scientific Affairs","keywords":"Medicine; Certolizumab pegol; Etanercept; Adalimumab; Golimumab; Psoriatic arthritis; Internal medicine; Discontinuation; Regimen; Ustekinumab; Oncology; Arthritis; Tumor necrosis factor alpha","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00006895104,0.0005476229,0.001366121,0.0006186859,0.0001590044,0.00005936803,0.0001142139,0.00005722026,0.0001272086],"category_scores_gemma":[0.00005280129,0.000399766,0.0002544606,0.0009874305,0.0001375866,0.0001180352,0.0000587662,0.00025042,0.00005465415],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00124335,"about_ca_system_score_gemma":0.0001281906,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003733188,"about_ca_topic_score_gemma":0.01826605,"domain_scores_codex":[0.9971496,0.00006415699,0.0007882484,0.0006872696,0.0007065643,0.0006041407],"domain_scores_gemma":[0.9983694,0.0006503238,0.0002090474,0.0004712096,0.00009703956,0.0002029896],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002518035,0.001800274,0.9365106,0.0001301883,0.0007850687,0.0004276184,0.003272283,0.000007672224,0.00000747008,0.0001826964,0.0002354478,0.05412261],"study_design_scores_gemma":[0.0219065,0.006836057,0.9650051,0.002626242,0.0005153534,0.000005375797,0.001184757,0.00008217284,0.0004845971,0.00001684212,0.0008209968,0.0005160347],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9890924,0.000699034,1.619574e-7,0.0004386172,0.001048501,0.001014265,0.0001840598,0.0001505562,0.007372462],"genre_scores_gemma":[0.9962251,0.0006349181,0.0002489471,0.00004379789,0.00007346924,0.0001047109,0.0001111646,0.00007791653,0.002480033],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05360657,"threshold_uncertainty_score":0.9998454,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03223907047043479,"score_gpt":0.3139645675392675,"score_spread":0.2817254970688328,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}